Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells
Ingrid Espinoza(National Heart Lung and Blood Institute), Ruth Lupu(Mayo Clinic in Arizona)
Cited by 11
Related Papers
Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity
|International Journal of Cancer|2005|109
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells
|Cell Death and Disease|2021|98
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
|Oncogenesis|2017|82
Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
|International Journal of Cancer|1995|70